Terumo Total Liabilities and Share Holders Equity 2012-2024 | TRUMY
Terumo total liabilities and share holders equity from 2012 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Terumo total liabilities and share holders equity for the quarter ending December 31, 2024 was $11.961B, a 0.04% decline year-over-year.
- Terumo total liabilities and share holders equity for 2024 was $12.637B, a 6.58% increase from 2023.
- Terumo total liabilities and share holders equity for 2023 was $11.856B, a 9.6% decline from 2022.
- Terumo total liabilities and share holders equity for 2022 was $13.116B, a 3.26% increase from 2021.
Terumo Annual Total Liabilities and Share Holders Equity (Millions of US $) |
2024 |
$12,637 |
2023 |
$11,856 |
2022 |
$13,116 |
2021 |
$12,701 |
2020 |
$11,420 |
2019 |
$10,087 |
2018 |
$9,711 |
2017 |
$9,499 |
2016 |
$7,484 |
2015 |
$9,071 |
2014 |
$8,328 |
2013 |
$9,329 |
2012 |
$8,795 |
Terumo Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
2024-06-30 |
$11,961 |
2023-06-30 |
$12,197 |
2022-06-30 |
$12,192 |
2021-06-30 |
$12,190 |
2020-06-30 |
$11,966 |
2019-06-30 |
$10,255 |
2018-06-30 |
$10,057 |
2017-06-30 |
$9,370 |
2016-06-30 |
$8,069 |
2015-06-30 |
$8,061 |
2015-03-31 |
$9,071 |
2014-12-31 |
$9,043 |
2014-09-30 |
$8,322 |
2014-06-30 |
$7,964 |
2014-03-31 |
$8,328 |
2013-12-31 |
$8,633 |
2013-09-30 |
$8,105 |
2013-06-30 |
$8,032 |
2013-03-31 |
$9,329 |
2012-12-31 |
$8,796 |
2012-09-30 |
$8,330 |
2012-06-30 |
$8,185 |
2012-03-31 |
$8,795 |
2011-12-31 |
$8,482 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$28.456B |
$6.386B |
Terumo Corporation is engaged in the manufacture and sales of medical products and equipment. The products offered by the Company covers General Hospital Products, Cardiac & Vascular Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo's Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer, electronic sphygmomanometer, urine test strip and leg compression stockings. Terumo Corporation is headquartered in Tokyo, Japan.
|